{
    "title": "J&J strikes $6.5 bln deal for autoimmune disease specialist Momenta",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8642983/Johnson--Johnson-buy-Momenta-6-5-bln.html",
    "date": "2020-08-19",
    "keywords": [
        "year",
        "deal",
        "disease",
        "nipocalimab",
        "johnson",
        "wednesday",
        "portfolio",
        "hardtotreat",
        "autoimmune",
        "acquisition",
        "spate",
        "biopharma",
        "inc",
        "pipeline",
        "incs",
        "humira",
        "drug",
        "unit",
        "access",
        "therapy",
        "latestage",
        "testing",
        "antibody",
        "anemia",
        "condition",
        "destruction",
        "blood",
        "midstage",
        "myasthenia",
        "gravis",
        "approval",
        "statement",
        "analyst",
        "thomas",
        "cambridge",
        "breadth",
        "offer",
        "price",
        "flurry",
        "activity",
        "time",
        "refinitiv",
        "value",
        "jampj",
        "one",
        "focus",
        "cancer",
        "bengaluru",
        "editing",
        "krauskopf",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}